The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

Desiree Rodriguez lost 35 pounds on a drug like Ozempic — but the tradeoff was losing “clumps” of her hair. She spoke to The Post about how she managed to minimize the hair loss.

Indian herbalists make extravagant claims for ashwagandha. But recent research shows that it offers significant sexual ...

Walmart Inc. is suing many of the nation’s largest pharmaceutical companies, alleging they colluded to inflate the price of ...

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...

The White House’s bid to install a vaccine-skeptic ally of HHS Secretary Robert F. Kennedy Jr. atop the CDC fell apart this ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...